Dabitra 110 Capsule

Dabitra 110 Capsule is a prescription anticoagulant that contains dabigatran etexilate 110 mg in each capsule. It belongs to the direct thrombin inhibitor class, which helps prevent harmful blood clots from forming. Doctors may use Dabitra 110 Capsule to lower the risk of stroke and blood clots in certain people with atrial fibrillation, and to treat or help prevent deep vein thrombosis and pulmonary embolism in appropriate patients. Because it affects clotting, it can also raise the risk of bleeding.

How it works: After you swallow Dabitra 110 Capsule, the capsule releases dabigatran etexilate, which is converted in the body to dabigatran. Dabigatran blocks thrombin, a key clot-forming protein, so blood is less likely to clot too easily.

Dabitra 110 Capsule is the 110 mg strength, which is a lower-strength option than Dabitra 150 Capsule. A doctor may choose Dabitra 110 Capsule for patients who need anticoagulation but may benefit from a less intensive dose based on age, kidney function, bleeding risk, and the condition being treated. It is not a generic starting dose for everyone, and the right strength depends on an individual assessment.

• Stroke prevention in non-valvular atrial fibrillation
• Treatment of deep vein thrombosis (DVT)
• Treatment of pulmonary embolism (PE)
• Prevention of repeat DVT or PE in selected patients
• Prevention of clots after certain medical situations when prescribed

• Swallow Dabitra 110 Capsule whole with a full glass of water; do not crush, chew, or open the capsule.
• Take it exactly as prescribed, usually at the same times each day.
• Do not put the capsule in your pill organizer if the container instructions say to keep it in the original packaging; moisture can affect this medicine.
• If your doctor tells you to switch between strengths, follow the new instructions carefully and do not double up.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; do not take two doses at once.
• Do not stop Dabitra 110 Capsule on your own, because stopping suddenly can increase clot risk.

Each Dabitra 110 Capsule provides dabigatran etexilate 110 mg per capsule. Depending on why you take it and how your doctor individualizes treatment, it may be taken once or twice daily; the prescribed schedule is specific to your condition and kidney function. There is no self-chosen maximum per day—your doctor sets the exact daily dose, and Dabitra 110 Capsule should be taken only as directed.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Dabigatran Etexilate may include:

• Bruising more easily
• Nosebleeds
• Stomach upset or abdominal pain
• Heartburn or indigestion
• Nausea
• Mild bleeding from gums or small cuts
• Loose stools

• Dabitra 110 Capsule can cause serious bleeding, so use caution if you have a history of ulcers, recent surgery, or bleeding problems.
• Tell your doctor if you have kidney disease, because dabigatran is cleared through the kidneys and dose choice depends on kidney function.
• Avoid taking other blood thinners or NSAIDs unless your doctor specifically says it is safe.
• Alcohol can increase bleeding risk, especially if you drink heavily.
• Tell every clinician, dentist, or surgeon that you take Dabitra 110 Capsule before any procedure or injection.
• Do not stop this medicine suddenly without medical advice, because clot risk can rise after interruption.
• If you have trouble swallowing capsules, ask your doctor or pharmacist before changing how you take it; the capsule form should not be opened or altered.

• Aspirin, clopidogrel, warfarin, heparin, and other anticoagulants can increase bleeding risk.
• NSAIDs such as ibuprofen and naproxen may raise the chance of bleeding.
• Strong P-gp inhibitors or inducers can change dabigatran levels and may require dose review.
• Certain heart medicines, including some antiarrhythmics, can interact and need pharmacist review.
• Herbal products like St. John's wort may reduce effectiveness and should be checked first.

Store Dabitra 110 Capsule in its original packaging at room temperature, away from moisture and out of reach of children.